Summit Medical
The Company
Product Information
Patient Information
Distributors
Education & Training
Contact
Home
Terms & Conditions


 
Hivac LogoMultiMix
Bone Cement Mixing and Delivery System

(Mixes up to 3 x 40g of low viscosity cement)
 
Features and benefits
  • Unique geared rotational axis mixing mechanism
    The primary paddle produces a reproducibly high quality mix of cement
  • Contra-rotating paddle
    The secondary paddle counter rotates in relation to the primary mixing paddle, scraping the side of the bowl and feeding cement back into the path of the primary mixing paddle. This produces reproducibly high quality mixes of low viscosity cement reducing dependency on operator skill.
  • Unique cement transfer gate
    • Unique cement transfer gate Allows simple, safe and clean transfer of cement from the mixing chamber to the delivery syringe
  • Large capacity mixing chamber
    A single, double or triple mix of low viscosity cement can be mixed and delivered
  • Narrow delivery syringe & efficient ratchet delivery gun
    Allows for greater “feel” on delivery and the opportunity to generate high cement pressure during pressurisation
  • Operating vacuum level of 550mmHg
    Allows cement to be mixed at optimal levels of porosity to maximise the mechanical properties of the cement – see fig 1, 2 & 3 below. Equalised vacuum between mixing chamber and delivery syringe allowing smooth cement transfer and minimal air inclusion.
  • Closed system using charcoal / microbiological filter
    Reduces MMA fumes in theatre to levels significantly below those set out in the HSE guidelines
  • Few components / simple to use design
    Easy to use system
  • High clarity material
    Allows the mixing process to be viewed from any position
  • Latex free product
    Provides protection against potential latex allergy for nursing staff and patients
  • PVC Free packaging
    Helps minimise environmental
 
Hivac Multimix Image
 
Research suggests that the quality of the cement mix is critical in achieving long term joint survival
 
Bone cement must be able to withstand the high and complex loading that it is subjected to through the lifetime of the implant.

"75% of revisions are caused by aseptic loosening" [1] and "mechanical failure of the cement mantle is the most common cause of aseptic loosening" [2]

During walking hip joint force exceeds 4 times body weight and this is applied cyclically [3].

Patients with hip/knee replacements take on average 5000 steps per day [4] and these conditions can lead to mechanical failure of the cement mantle [5] and [6]. Therefore the mechanical properties of the cement should be optimised to prevent failure.

Figure 1 shows that the HiVac™ MultiMix produces cement with enhanced Compressive and Bending strength compared to other commercially available systems. In addition Figure 2 shows that bending modulus is also enhanced with the MultiMix product.

To further enhance the mechanical properties of the cement it needs to be mixed under optimal vacuum levels. If the vacuum level is too low then the cement will contain high levels of porosity, but if too high excessive thermal shrinkage can create cracking in the cement mantle. The HiVac™ range operates at 550mmHg, which has been proven to provide an optimal balance between the two.

Exposure to MMA fumes is a concern of many that work in the vicinity of bone cement mixing. HSE recommend a maximum exposure for these fumes of 100ppm during a 15 minute exposure. The HiVac™ range uses charcoal filters that reduce fume exposure down to levels that are only a small fraction of these guideline limits. Figure 4.
 
click on an image for a larger version
Figure 1
Figure 2
Figure 3
Figure 4
  
 
  1. Malchau H, Herberts P, Soderman P and Oden A, 2000. Update from the Swedish National Hip Athroplasty Registry 1979-1998. Scientific exhibit AAOS, March 15-19, Orlando, Florida, USA.
     
  2. James SP, Jasty M, Davies J, Piehier H and Harris WH, 1992. A fractographic investigation of MMA bone cement focussing on the relationship between porosity reduction and increased fatigue life. J Biomechanical Materials Res, 26, 651-662
     
  3. Paul, 1976. Approaches to design; Force actions transmitted by joints in the human body. Proc R Soc Lond B, 192, 163-172
     
  4. Schmalzried TP, Szuszczewicz ES, Northfield MS, Akizuki KH, Belcher and Amstutz HC, 1998. Quantitive assessment of walking activity after total hip or knee replacement. J Bone Surgery, 80A (1), 54-59
     
  5. Jasty M, Maloney WJ, and Bragdon CR, 1991. The initiation of failure in cemented femoral components of hip arthoplasties. J Bone & Joint Surgery, 73B, 551-558.
     
  6. Topoleski LDT, Ducheyne P and Cuckler JM, 1990. A fractographic analysis of in vivo polymethlmethacrylate bone cement failure mechanisms. J Biomed Materials Res, 24, 145-154
 
UK and Export
For further information and details of availability of these products by country please contact:
info@summit-medical.co.uk
 
Effective, Progressive, Innovative

Back to Top
 
Summit Medical Limited
Industrial Park, Bourton on the Water, Gloucestershire, GL54 2HQ, United Kingdom

Tel: +44 (0) 1451 821311, Fax: +44 (0) 1451 821092
Customer Services Tel: +44 (0) 1451 810900, Customer Services Fax: +44 (0) 1451 822302
e-mail:
info@summit-medical.co.uk